EXECUTIVE SEARCH · BOSTON

Executive Search in
Boston

Senior leadership for the densest concentration of biotech, academic-medical and asset-management capital in the United States. Retained CEO, CMO and CSO mandates across life sciences, healthcare systems, EdTech and industrial technology.

Brief Us On A Mandate See Our Process

120+

CXO Mandates Closed

Last 24 months, global

94%

On-Shortlist Retention

After first slate

95–120 Days

Time-to-Placement

Typical retained mandate

12 Months

Candidate Guarantee

Replacement included

Cost Structure

Cambridge-grade rigor. India-based cost structure.

Boston biotech and asset-management retainers carry some of the highest fee benchmarks in US executive search. Our retainer is meaningfully lower because the research desk and senior partners operate from India, not because the work is. The slate, the calibration memo and the assessment dossiers are built to the standard a Cambridge or Boston board would apply to any retained firm.

Proof

Senior partner on every search

The named partner runs the longlist, the approach and the offer; nothing is delegated to a coordinator after the brief.

Proof

12-month replacement

If the placed candidate departs in the first twelve months, we re-run the search at no additional retainer.

Proof

No outsourced research

The talent map is built in-house — we do not buy lists or subcontract sourcing offshore.

Typically 30–45% lower retainer than equivalent Boston or Cambridge boutiques

Two Tracks

How a Boston-anchored mandate runs

Two operating tracks for two distinct mandate types — chosen at the calibration stage, not after.

India → Boston life-sciences leadership

For Indian generics, biosimilar and CDMO groups building a US clinical, commercial or regulatory presence in Boston, leadership has to read both an FDA-perimeter cycle and an India promoter board. We hire executives who already operate that lane, and who understand the difference between a Hyderabad API site and a Cambridge IND submission with the same fluency.

FDA-perimeter literacy — leaders with hands-on IND, BLA and 483-response experience
India clinical-and-API bench — leadership credentialed across Hyderabad, Bengaluru and Mumbai sites
Cross-border governance — listed-parent disclosure plus US subsidiary board cadence
Returning-diaspora benches — senior India-origin scientists and commercial leaders inside US biotech

Discuss a cross-border mandate

Boston local leadership hiring

For a Boston-domiciled biotech, hospital network, asset manager or EdTech business, the search is anchored in the Cambridge–Longwood–Seaport corridor. Compensation comparators come from the local listed and venture-backed peer set, and the talent map names the institutions people genuinely move between rather than the broader Northeast average.

Cambridge-Longwood-Seaport calibration — peer comparators built off the genuine Boston peer set
Pre-IPO and listed biotech — CMO, CSO, CFO and CEO mandates across stage
Academic-medical centre leadership — chief operating, chief financial and chief medical roles
Long-only and quant asset management — investment and operating leadership across the Boston AM cluster

Discuss a local Boston mandate

What We Search

C-suite roles we search in Boston

CEO / Managing Director

CFO

CHRO

CTO / CIO

CMO

COO

CRO (Revenue)

Chief Strategy / Legal Officer

Chief Product Officer

Board & Non-Executive Director

Sectors we serve from Boston

Life Sciences & Biotech
The deepest pre-clinical, clinical-stage and commercial biotech leadership pool in the United States — CEO, CMO, CSO and CRO mandates dominate volume.
Asset Management
Long-only, quantitative and multi-asset leadership — the Boston asset-management cluster is the second-largest in the US after New York.
Healthcare Systems & Academic Medical Centres
Chief operating, chief medical and chief financial mandates inside large academic-medical and integrated delivery networks.
EdTech & Higher-Education Operators
Leadership for online-learning platforms, university operating companies and education-technology businesses anchored by the Boston academic ecosystem.
Industrial & Climate Technology
Chief executive, chief technology and chief operating roles for industrial-tech and climate-tech businesses spinning out of MIT and Greater Boston.
MedTech & Diagnostics
Device, diagnostics and digital-health leadership — commercial and clinical mandates across the Greater Boston MedTech belt.
Health Insurance & Managed Care
Chief medical officer, chief actuary and chief operating roles inside regional and national managed-care groups headquartered in the metro.
CRO, CDMO & Clinical Services
Cross-border leadership where US clinical operations sit alongside Indian API or clinical-research footprints.

Market Context

Why leadership hiring in Boston is different

Boston is the only US metro where biotech is the dominant leadership market — not a sub-segment of healthcare, but the centre of gravity. That changes the shape of every search. Compensation is heavily weighted toward equity at the pre-clinical and clinical-stage level, and the talent map is constructed company-by-company rather than by a generic comparator set.

The asset-management cluster is the second anchor. Long-only and quantitative investment leadership operate alongside the biotech ecosystem in a way that produces a distinctive cross-pollination — chief financial officer benches, in particular, often move between the two — and we calibrate searches to that reality rather than treating the segments separately.

For Indian-origin groups, Boston is the single most important US gateway for clinical and regulatory leadership. The bench of senior India-origin scientists, regulatory heads and commercial leaders inside Cambridge biotech is unusually deep, and we have spent years tracking who is genuinely operating cross-border rather than simply US-resident.

TIME ZONE

ET (UTC−5 / −4 DST)

PRIMARY REGULATORS

FDA, MassDPH, SEC, FINRA

ANCHOR SECTORS

Biotech, Asset Mgmt, Healthcare, EdTech

TALENT FLOW

Bidirectional with Hyderabad clinical and Bengaluru research

COMP CURRENCY

USD — equity-heavy at pre-clinical and clinical stage

The Process

Six steps. One discipline.

Our six-step retained search process is the same across every location — what changes is the talent map and the cultural lens. We start by understanding the operating cadence between your headquarters and the markets the leader must serve.

Mandate Calibration

We read the operating cadence between your headquarters and the markets the leader will serve, then convert the brief into a written calibration memo with the success measures the slate will be judged against.

Week 1

Talent-Map Build

Our research desk constructs a city-anchored talent map covering incumbents at the role plus high-potential next-rung candidates. The map is shared before approach begins, so you see which lanes we hunt and which we skip.

Weeks 1–2

Targeted Approach

A senior partner approaches the longlist personally, off-platform, with the same discretion the role itself will demand of its eventual holder. We never publish the search.

Weeks 2–4

Assessment & Calibration

Each candidate is evaluated against the calibration memo. Structured references and a written assessment dossier are shared with your selection committee — no candidate enters the slate without one.

Weeks 4–7

Slate & Selection

We present a five-name shortlist with a slate ranking, an attempt-to-hire view, and the trade-offs we would accept or reject ourselves. The committee meets the slate; we do not.

Weeks 6–9

Offer & Onboarding Bridge

We carry the offer construction, manage the resignation runway, and stay engaged through the first hundred days. The 12-month replacement guarantee runs from the candidate's start date.

Weeks 8–12+

From The Boardroom

What clients say about Boston mandates

Archetype attributions — never real names, never real companies.

“Our previous partner kept showing us candidates who looked good on paper and then could not pass a clinical-stage diligence call. This team built the slate around the diligence call, not the resume. The hire took us through our IND filing without a wobble.”

Founder & CEO archetype · Pre-clinical biotech platform · Cambridge

A Chief Medical Officer mandate in advance of an IND filing.

“We needed a CFO who had run a US-listed biotech and was comfortable inside an Indian promoter board. That bench is small. The slate had four credible names. The placed leader is now on both committees and the cadence is unrecognisable from twelve months ago.”

Group CFO archetype · India-listed biopharma group · Boston US subsidiary

A US-subsidiary CFO appointment for an India-listed pharma parent.

“The differentiator was the assessment dossier. By the time we met candidate three our committee was using language from the calibration memo to discuss the trade-offs. That memo is the artefact I would point to as the reason the firm earned the next two mandates.”

Board Chair archetype · Multi-strategy asset management firm · Boston

A first-time Chief Operating Officer appointment for a long-only asset manager.

FAQs

Frequently asked — executive search in Boston

Answers to the questions boards most often ask before retaining a search partner for a Boston-anchored mandate.

Most retained mandates close in 95–120 days. Pre-clinical and clinical-stage biotech CEO and CMO searches sit at the longer end of that range because the diligence calls and reference work are more involved; asset-management and EdTech searches typically close inside twelve weeks.

Yes. We treat FDA-perimeter roles — Chief Medical Officer, Chief Regulatory Officer, head-of-clinical-development — as core to the Boston practice. Each candidate's regulatory history is validated through structured references and public-record review before they enter the slate.

Yes. For Indian-headquartered pharma, biosimilar and CDMO groups building Boston commercial or clinical leadership, we routinely run a single search whose slate spans both geographies, with one senior partner accountable for the whole map.

Our retainer is typically 30–45% lower than equivalent Boston or Cambridge boutiques. The structure is identical — a flat fee billed in three tranches across the search — and we share the schedule before any work begins.

Either, at the client's election. India-listed groups usually invoice INR against the parent entity; US-domiciled biotech and asset-management clients invoice USD against the local entity.

If the placed candidate departs the role within twelve months of start date for reasons other than a board-led restructuring, we re-run the search at no additional retainer. The guarantee runs from start date so the onboarding window is genuinely covered.

No. Gladwin International is an independent retained search firm with its own research desk and partner bench. We are not a sub-contractor and do not share candidate data with any global retained firm.

Both. The Boston practice runs CMO, CSO and head-of-clinical-development mandates alongside CEO, CFO and head-of-commercial roles. The same senior partner can run either lane.

Engage

Brief us on a Boston-anchored mandate

Conversations are confidential, partner-led, and carry no obligation to retain. A senior practice partner reviews every enquiry personally and responds within four business hours.